false

/content/advancedmaterials/us/en/search-results.html

What Is a Dual-Sensory Experience? How Immediate Cooling and API Action Are Shaping OTC Topical Analgesics

Competition is intensifying across the over-the-counter (OTC) topical pain relief market.

Effective active pharmaceutical ingredients (APIs) remain essential, but they are no longer enough to differentiate products in an increasingly competitive market. Today's consumers expect spray and aerosol products that work quickly, feel comfortable on the skin and deliver a premium user experience from the first application.

For formulators and brand owners, that means looking beyond the API alone. Increasingly, product differentiation is being achieved through formulation innovation, with propellant technology emerging as an important contributor to product performance and consumer experience.

One of the most promising developments is a dual-sensory experience that pairs an immediate physical cooling sensation with the API's analgesic effect.

What is a dual-sensory experience?

Traditional OTC topical analgesics rely on active pharmaceutical ingredients to deliver therapeutic relief. While these ingredients are highly effective, they require time to reach their full therapeutic effect.

This formulation design adds a second sensory dimension: an immediate cooling sensation at the point of application.

By pairing an API with Solstice® Propellant, HFO-1234ze(E), formulators can create a two-stage sensory experience: an immediate cooling sensation from the moment of application followed by the API's analgesic effect.

Current Topical Analgesic Dual-Sensory Experience
Reduces pain by targeting the nerves using APIs that require time to take effect. APIs do not numb the skin. Immediate physical skin-cooling sensation from Solstice Propellant, followed by the API's sustained analgesic effect.

For consumers, this creates an earlier sensory indication of cooling, which is a sensory effect of the propellant and is not itself an indicator of analgesic efficacy, which is attributable to the API. For brands, it provides an opportunity to differentiate products through formulation design rather than relying solely on the API.

Bringing Solstice Propellant cooling technology to OTC topical analgesics

Solstice Propellant technology is already proven in applications for rapid skin cooling at the point of care (Ref. 1).

Solstice scientists have demonstrated how this technology can be used in OTC topical analgesic formulations, allowing brands to combine this cooling performance with the convenience and accessibility of consumer healthcare products.

Rather than functioning solely as a delivery mechanism, Solstice Propellant can enhance the overall sensory and user experience.

Why propellant selection matters

Selecting the right propellant influences far more than aerosol delivery.

It affects spray characteristics, cooling performance, formulation stability and the overall sensory experience of the finished product.

Customizable cooling performance

The cooling experience plays an important role in how consumers perceive product performance.

Cooling that is too weak may go unnoticed, while cooling that is too intense can be uncomfortable. Solstice Propellant enables cooling performance to be customized through formulation design, blend ratios and hardware selection, allowing formulators to optimize the sensory experience for different product concepts.

Surface Temperature Profiles: Popular Brands versus Solstice Prototype Line chart comparing skin-surface temperature over 100 seconds after application. Four unnamed popular-brand products swing sharply too warm or too cold before settling; the Solstice Prototype line dips moderately and stabilizes in a comfortable middle range. Surface Temperature Profiles: Popular Brands versus Solstice Prototype 38 27 16 5 -6 -17 -40 0 10 20 30 40 50 60 70 80 90 100 Temperature (°C) Time (seconds) TOO WARM TOO COLD
OTC Prototype with Solstice Propellant

Note: OTC = over the counter

Figure 1: Immediate cooling sensation from Solstice Propellant paired with the API's analgesic effect. (Ref. 2)

Premium sensory formats

Solstice Propellant supports a wide range of differentiated product formats, including rich, creamy foams, precise fine mist sprays and larger stream-like spray patterns. Compared with hydrocarbon propellants, internal testing indicates it can enable enhanced spreadability and a smoother feel on the skin (Ref. 2), supporting brands in developing a differentiated consumer experience.

Unlike bag-on-valve (BOV) systems, which use compressed gas to expel the formulation from an internal bag, aerosol systems with Solstice Propellant provide consistent spray pressure and performance throughout the life of the product.

Demonstrated compatibility with common OTC APIs

Successful formulation requires confidence that performance is matched by stability.

In a three-month study (Ref. 2), Solstice has demonstrated compatibility in formulations containing Solstice Propellant and ethanol, giving formulators a documented starting point, based on internal testing, for both new product development and reformulation.

  • Benzocaine.
  • Benzethonium chloride.
  • Menthol.
  • Chlorhexidine digluconate.
  • Lidocaine.
  • Camphor.
  • Methyl salicylate.

Reducing risk throughout product development

Developing a differentiated OTC topical analgesic requires more than selecting the right propellant.

With more than five decades of combined propellant innovation, Solstice works directly with brand owners, formulators and manufacturing partners to help accelerate development and reduce formulation risk.

The future of OTC topical analgesics starts with formulation innovation

As consumer expectations continue to evolve, differentiation increasingly depends on more than therapeutic efficacy alone.

By combining an immediate physical skin cooling sensation with sustained API-driven analgesic action, enabling premium sensory formats and supporting future-ready formulations, formulators can use Solstice Propellant to create differentiated OTC topical analgesic products.

Want to learn how Solstice Propellant can support your next OTC topical analgesic formulation? Contact our technical team to discuss your development program.

References

The brand owner and manufacturer are responsible for finished-product safety, flammability, labeling, and OTC monograph compliance.

  1. As demonstrated by a commercially available topical anesthetic spray containing Solstice Propellant.
  2. Supporting data from Solstice internal attributes, foam property and feel, temperature and chemical compatibility testing. For more information, contact us at https://www.solstice.com/us/en/contact-us/sales-inquiry/solvents-propellants

Although Solstice believes that the information contained herein is accurate and reliable, it is presented without guarantee or responsibility of any kind and does not constitute any representation or warranty of Solstice Advanced Materials US, Inc., either expressed or implied. This content is provided for informational purposes only and does not constitute legal advice and should not be acted upon as such. This information may not be current and is subject to change without notice or obligation to update. Information provided herein does not relieve the user from the responsibility of carrying out its own analysis, and the user assumes all risks and liabilities (including, but not limited to, risks relating to regulatory compliance and IP infringement) related to the use of Solstice products and/or information contained herein.